Company Overview and News
KUALA LUMPUR, Aug 15 — Berjaya Food (BFood) Bhd will further cement its presence in the Indian market with the opening of 30 Kenny Rogers Roasters (KRR) restaurants and 75 Jollibean kiosks through its development agent, World Iconic Brand (WIB) Hospitality Pvt Ltd India.
KUALA LUMPUR (Aug 15): Berjaya Food Bhd (BFood) will be opening at least 30 more Kenny Rogers Roasters (KRR) outlets and 75 Jollibean kiosks in India, via a partnership with World Iconic Brands (WIB) Hospitality Private Ltd inked today.
KUALA LUMPUR (July 4): The outlook for the local equity market looks positive for the next twelve to eighteen months, backed by steady economic growth, according to AmInvestment Bank Research.
5258 PBLOF 5196 7237 1295
Berjaya Food Bhd (June 22, RM1.62) Maintain hold with a lower target price of RM1.74: Berjaya Food Bhd (BFood) reported a turnover of RM160 million, up 5.7% year-on-year (y-o-y), while core net profit surged 50% y-o-y to RM2.4 million for its fourth quarter of financial year 2018 (4QFY18). This brought its full-year FY18 core net profit to RM19.3 million — after stripping out one-off RM15.3 million loss from the disposal of Kenny Rogers Roasters (KRR) Indonesia — which disappointed both our and Bloomberg consensus expectations, at 93% and 87% of the respective forecasts.
KUALA LUMPUR (June 22): CIMB Research said today Berjaya Food Bhd's Starbucks operations in Malaysia will continue to sustain Berjaya Food's earnings growth on expectation of 25 to 30 Starbucks outlets to be opened per year.
KUALA LUMPUR: Berjaya Food Bhd’s share price edges lower despite returning to the black in the fourth quarter ended April 30 on Starbucks boost.
KUALA LUMPUR (June 22): The FBM KLCI is expected to remain under pressure today in line with the overnight fall at most global markets, and stay below the 1,700-point level.
5139 0900 9539 5196
KUALA LUMPUR (June 21): Based on corporate announcements and news flow today, companies in focus on Friday (June 22) may include the following: Jag Bhd, Berjaya Food Bhd, Sapura Energy Bhd, XOX Bhd, Aeon Credit Service (M) Bhd and Multi-Usage Holdings Bhd.
5139 0900 9539 5196
KUALA LUMPUR (June 21): Berjaya Food Bhd returned to the black in the final quarter of its financial year 2018 with a net profit of RM837,000 against a net loss of RM3.37 million in the same quarter a year ago, as revenue improved with more Starbucks cafes in operation during the quarter.
At lunch break, Berjaya Food’s share price in Bursa Malaysia eased eight sen to RM1.75 with 241,800 shares traded. — Reuters picKUALA LUMPUR, March 16 — RHB Research is positive on food and beverages chain operator, Berjaya Food Bhd, on the back of sustainable growth driven by Starbucks through expansion of outlets and better consumer sentiment moving forward.
5196 BSMAF 1818
1h - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
1h - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2h - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...